Insight
Praveen Kumar Marimuthu
Praveen Kumar Marimuthu/X

Praveen Kumar Marimuthu: Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III NSCLC

Praveen Kumar Marimuthu, DM Resident – Medical oncology at Christian Medical College and Hospital, shared a post on X:

” ‘When Less Is Truly More’

Excited to share our work from Med Onc CMC Vellore published in JCO Global Oncology.

‘Does adding low dose Nivo to NACT response rates and survival in stage III non-oncogene-driven NSCLC?’
Mentor – Ashish Singh
Key findings.”

“Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non–Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score–Matched Analysis”

Authors: Praveen Kumar Marimuthu et al.

Praveen Kumar Marimuthu: Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III NSCLC

Ashish Singh cancer chemotherapy JCO Global Oncology NSCLC OncoDaily Oncology Praveen Kumar Marimuthu